冥想与瑜伽辅助治疗间质性膀胱炎-膀胱疼痛综合征:一项随机对照试验
这项随机试验比较了仅接受标准治疗(对照组)与在标准治疗基础上加用冥想和瑜伽(身心组)的间质性膀胱炎-膀胱疼痛综合征女性患者。12周时,身心组的改良GRA应答率显著高于对照组(72.1% vs 25.6%,RR 2.8,95%CI 1.6-4.6),且治疗升级需求更低(4.4% vs 33.3%,RR 0.13,95%CI 0.03-0.55)。结论认为,在标准治疗基础上加用冥想和瑜伽与改善治疗应答相关,且需要更少的额外干预。
要点
- 12周时身心组GRA应答者31/43(72.1%),对照组10/39(25.6%),RR 2.8(95%CI 1.6-4.6)。
- 身心组治疗升级2/45(4.4%),对照组14/42(33.3%),RR 0.13(95%CI 0.03-0.55)。
- ICPI、ICSI和疼痛评分的有利变化RR分别为1.8(95%CI 0.5-3.1)、1.9(95%CI 0.2-3.6)和1.4(95%CI 0.4-2.5)。
核心结论
- 在标准间质性膀胱炎-膀胱疼痛综合征治疗基础上加用冥想和瑜伽,与改善治疗应答相关,且与仅标准治疗相比需要更少的额外干预。
研究设计与样本
- 随机试验,比较仅接受标准治疗的对照组与接受标准治疗加冥想和瑜伽的身心组。
- 共随机97名女性(身心组49名,对照组48名)。
- 标准治疗定义为美国泌尿协会推荐的行为改变或药物治疗。
- 主要结局为12周时改良GRA,比较应答者(中度、显著改善)与非应答者。
- 功效分析假设α=5%、β=80%,需82名参与者以发现组间GRA 30%的差异。
主要发现
- 12周时身心组GRA应答者31/43(72.1%),对照组10/39(25.6%),RR 2.8(95%CI 1.6-4.6)。
- 12周内每周GRA评分支持身心组优于对照组。
- 12周时身心组ICPI有利变化RR 1.8(95%CI 0.5-3.1),ICSI有利变化RR 1.9(95%CI 0.2-3.6),疼痛有利变化RR 1.4(95%CI 0.4-2.5),均优于对照组。
- 身心组治疗升级2/45(4.4%),对照组14/42(33.3%),RR 0.13(95%CI 0.03-0.55)。
临床怎么用
- 原文结论认为,在标准治疗基础上加用冥想和瑜伽与改善治疗应答相关,且需要更少的额外干预。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether yoga and meditation added to usual care improves treatment response in women with interstitial cystitis-bladder pain syndrome. METHODS: This randomized trial compared women with interstitial cystitis-bladder pain syndrome receiving standard care alone (control group) with those receiving standard care plus meditation and yoga (mind-body group). Standard care was defined as behavioral changes or medications recommended by the American Urological Association. Individuals in the control group received standard care, and those in the mind-body group received standard care augmented with a commercially available meditation application and standardized yoga tutorial video. Both groups continued their current interstitial cystitis-bladder pain syndrome standard care treatments. The primary outcome was the modified GRA (Global Response Assessment), comparing responders (moderately, markedly improved) with nonresponders at 12 weeks. On power analysis assuming α=5% and β=80%, a sample size of 82 participants was required to find 30% difference on the GRA between groups. Weekly GRA scores over 12 weeks were also compared. Secondary outcomes included ICPI (Interstitial Cystitis Problem Index)/ICSI (Interstitial Cystitis Symptom Index), pain, pain interference, anxiety/depression, and self-efficacy scores and treatment escalation over 12 weeks. RESULTS: Among 97 randomized participants (49 mind-body group, 48 control group), groups did not differ in characteristics or symptoms at baseline. The mind-body group had more GRA responders compared with the control group at 12 weeks (31/43 [72.1%] vs 10/39 [25.6%], relative risk [RR] 2.8, 95% CI, 1.6-4.6), corroborated by superior weekly GRA results over 12 weeks. The mind-body group had superior beneficial change on the ICPI (RR 1.8, 95% CI, 0.5-3.1), ICSI (RR 1.9, 95% CI, 0.2-3.6), and pain (RR 1.4, 95% CI, 0.4-2.5) scores than the control group at 12 weeks. The mind-body group required less treatment escalation than the control group (2/45 [4.4%] vs 14/42 [33.3%], RR 0.13, 95% CI, 0.03-0.55). CONCLUSION: The addition of meditation and yoga to standard interstitial cystitis-bladder pain syndrome care was associated with improved treatment response and required fewer additional interventions compared with standard care alone. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT04820855.
引用
- Dao AN, Komesu YM, Jansen SM, et al. Augmentation of Interstitial Cystitis-Bladder Pain Syndrome Treatment With Meditation and Yoga: A Randomized Controlled Trial. Obstet Gynecol. 2025. PMID: 39746210. doi:10.1097/AOG.0000000000005820
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。